Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123


Cell cycle-dependent conjugation of endogenous BRCA1 protein with SUMO-2/3.

Vialter A, Vincent A, Demidem A, Morvan D, Stepien G, Venezia ND, Rio PG.

Biochim Biophys Acta. 2011 Apr;1810(4):432-8. doi: 10.1016/j.bbagen.2010.12.001. Epub 2010 Dec 13.


System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability.

Xiao Z, Chang JG, Hendriks IA, Sigurðsson JO, Olsen JV, Vertegaal AC.

Mol Cell Proteomics. 2015 May;14(5):1419-34. doi: 10.1074/mcp.O114.044792. Epub 2015 Mar 9.


Rap80 protein recruitment to DNA double-strand breaks requires binding to both small ubiquitin-like modifier (SUMO) and ubiquitin conjugates.

Hu X, Paul A, Wang B.

J Biol Chem. 2012 Jul 20;287(30):25510-9. doi: 10.1074/jbc.M112.374116. Epub 2012 Jun 11.


The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.

Morris JR, Boutell C, Keppler M, Densham R, Weekes D, Alamshah A, Butler L, Galanty Y, Pangon L, Kiuchi T, Ng T, Solomon E.

Nature. 2009 Dec 17;462(7275):886-90. doi: 10.1038/nature08593.


SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins.

Bayona JC, Nakayasu ES, Laverrière M, Aguilar C, Sobreira TJ, Choi H, Nesvizhskii AI, Almeida IC, Cazzulo JJ, Alvarez VE.

Mol Cell Proteomics. 2011 Dec;10(12):M110.007369. doi: 10.1074/mcp.M110.007369. Epub 2011 Aug 10.


Transcription regulation of nuclear receptor PXR: Role of SUMO-1 modification and NDSM in receptor function.

Priyanka, Kotiya D, Rana M, Subbarao N, Puri N, Tyagi RK.

Mol Cell Endocrinol. 2016 Jan 15;420:194-207. doi: 10.1016/j.mce.2015.11.001. Epub 2015 Nov 5.


RNF4-dependent hybrid SUMO-ubiquitin chains are signals for RAP80 and thereby mediate the recruitment of BRCA1 to sites of DNA damage.

Guzzo CM, Berndsen CE, Zhu J, Gupta V, Datta A, Greenberg RA, Wolberger C, Matunis MJ.

Sci Signal. 2012 Dec 4;5(253):ra88. doi: 10.1126/scisignal.2003485.


Identification of biochemically distinct properties of the small ubiquitin-related modifier (SUMO) conjugation pathway in Plasmodium falciparum.

Reiter K, Mukhopadhyay D, Zhang H, Boucher LE, Kumar N, Bosch J, Matunis MJ.

J Biol Chem. 2013 Sep 27;288(39):27724-36. doi: 10.1074/jbc.M113.498410. Epub 2013 Aug 13.


The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.

Gareau JR, Lima CD.

Nat Rev Mol Cell Biol. 2010 Dec;11(12):861-71. doi: 10.1038/nrm3011. Review.


MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.

Stindt MH, Carter S, Vigneron AM, Ryan KM, Vousden KH.

Cell Cycle. 2011 Sep 15;10(18):3176-88. Epub 2011 Sep 15.


Diversification of SUMO-activating enzyme in Arabidopsis: implications in SUMO conjugation.

Castaño-Miquel L, Seguí J, Manrique S, Teixeira I, Carretero-Paulet L, Atencio F, Lois LM.

Mol Plant. 2013 Sep;6(5):1646-60. doi: 10.1093/mp/sst049. Epub 2013 Mar 12.


Sumoylation regulates nuclear localization and function of zinc finger transcription factor ZIC3.

Chen L, Ma Y, Qian L, Wang J.

Biochim Biophys Acta. 2013 Dec;1833(12):2725-33. doi: 10.1016/j.bbamcr.2013.07.009. Epub 2013 Jul 19.


Small Ubiquitin-like Modifier Alters IFN Response.

Maarifi G, Maroui MA, Dutrieux J, Dianoux L, Nisole S, Chelbi-Alix MK.

J Immunol. 2015 Sep 1;195(5):2312-24. doi: 10.4049/jimmunol.1500035. Epub 2015 Jul 29.


c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.

González-Prieto R, Cuijpers SA, Kumar R, Hendriks IA, Vertegaal AC.

Cell Cycle. 2015;14(12):1859-72. doi: 10.1080/15384101.2015.1040965.


Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.

Yang W, Wang L, Roehn G, Pearlstein RD, Ali-Osman F, Pan H, Goldbrunner R, Krantz M, Harms C, Paschen W.

Cancer Sci. 2013 Jan;104(1):70-7. doi: 10.1111/cas.12047. Epub 2012 Nov 28. Erratum in: Cancer Sci. 2013 Feb;104(2):274.


Identification of a novel post-translational modification in Plasmodium falciparum: protein sumoylation in different cellular compartments.

Issar N, Roux E, Mattei D, Scherf A.

Cell Microbiol. 2008 Oct;10(10):1999-2011. doi: 10.1111/j.1462-5822.2008.01183.x. Epub 2008 Jun 10.


Analysis of changes in SUMO-2/3 modification during breast cancer progression and metastasis.

Subramonian D, Raghunayakula S, Olsen JV, Beningo KA, Paschen W, Zhang XD.

J Proteome Res. 2014 Sep 5;13(9):3905-18. doi: 10.1021/pr500119a. Epub 2014 Aug 7.


Molecular characterization of SUMO E2 conjugation enzyme: differential expression profile in Schistosoma mansoni.

Pereira RV, Cabral FJ, Gomes MS, Baba EH, Jannotti-Passos LK, Carvalho O, Rodrigues V, Afonso RJ, Castro-Borges W, Guerra-Sá R.

Parasitol Res. 2011 Dec;109(6):1537-46. doi: 10.1007/s00436-011-2394-4. Epub 2011 May 15.


Pax8 protein stability is controlled by sumoylation.

de Cristofaro T, Mascia A, Pappalardo A, D'Andrea B, Nitsch L, Zannini M.

J Mol Endocrinol. 2009 Jan;42(1):35-46. doi: 10.1677/JME-08-0100. Epub 2008 Oct 30.


Supplemental Content

Support Center